These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
61-1547850
|
|
(State or other jurisdiction
|
(I.R.S. Employer Identification Number)
|
|
of incorporation or organization)
|
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
|
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
x
.
|
|
|
(Do not check if a smaller reporting company)
|
||||
|
Page
|
||
|
PART I – FINANCIAL INFORMATION:
|
||
|
Item 1.
|
Financial Statements (unaudited):
|
|
|
Condensed Balance Sheets as of March 31, 2011 and December 31, 2010
|
1
|
|
|
Condensed Statements of Operations for the Three Months Ended March 31, 2011 and 2010 and for the Cumulative Period from November 16, 2007 (Inception) to March 31, 2011
|
2
|
|
|
Condensed Statements of Cash Flows for the Three Months Ended March 31, 2011 and 2010 and for the Cumulative Period from November 16, 2007 (Inception) through March 31, 2011
|
3
|
|
|
Notes to Condensed Financial Statements
|
4
|
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
7
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
10
|
|
Item 4.
|
Controls and Procedures
|
10
|
|
PART II – OTHER INFORMATION
:
|
||
|
Item 1.
|
Legal Proceedings
|
10
|
|
Item 1A.
|
Risk Factors
|
10
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
10
|
|
Item 3.
|
Defaults Upon Senior Securities
|
11
|
|
Item 4.
|
Removed and Reserved
|
11
|
|
Item 5.
|
Other Information
|
11
|
|
Item 6.
|
Exhibits
|
11
|
|
Signatures
|
12
|
|
|
March 31,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
(Unaudited)
|
||||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 24,634 | $ | 26,898 | ||||
|
Prepaid expenses
|
625 | 2,500 | ||||||
|
Total assets
|
$ | 25,259 | $ | 29,398 | ||||
|
Liabilities and stockholders' deficit
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 11,404 | $ | 10,389 | ||||
|
Notes payable, stockholders
|
60,000 | 60,000 | ||||||
|
Total liabilities
|
71,404 | 70,389 | ||||||
|
Stockholders' deficit
|
||||||||
|
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding
|
- | - | ||||||
|
Common stock, $0.0001 par value; 100,000,000 shares authorized; 5,000,000 shares issued and outstanding
|
500 | 500 | ||||||
|
Additional paid-in capital
|
49,500 | 49,500 | ||||||
|
Deficit accumulated during the development stage
|
(96,145 | ) | (90,991 | ) | ||||
|
Total stockholders' deficit
|
(46,145 | ) | (40,991 | ) | ||||
|
Total liabilities and stockholders' deficit
|
$ | 25,259 | $ | 29,398 | ||||
|
Cumulative
|
||||||||||||
|
Period From
|
||||||||||||
|
Three Months Ended
|
November 16, 2007
|
|||||||||||
|
March 31,
|
(Inception) Through
|
|||||||||||
|
2011
|
2010
|
March 31, 2011
|
||||||||||
|
Operating expenses:
|
||||||||||||
|
Formation costs
|
$ | - | $ | - | $ | 15,643 | ||||||
|
General and administrative
|
4,266 | 3,936 | 76,890 | |||||||||
|
Operating loss
|
(4,266 | ) | (3,936 | ) | (92,533 | ) | ||||||
|
Interest expense
|
888 | 370 | 3,612 | |||||||||
|
Net loss
|
$ | (5,154 | ) | $ | (4,306 | ) | $ | (96,145 | ) | |||
|
Net loss per basic and diluted common share
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.02 | ) | |||
|
Weighted-average number of common shares outstanding
|
5,000,000 | 5,000,000 | 4,886,271 | |||||||||
|
Cumulative
|
||||||||||||
|
Period From
|
||||||||||||
|
Three Months Ended
|
November 16, 2007
|
|||||||||||
|
March 31,
|
(Inception) Through
|
|||||||||||
|
2011
|
2010
|
March 31, 2011
|
||||||||||
|
Operating activities
|
||||||||||||
|
Net loss
|
$ | (5,154 | ) | $ | (4,306 | ) | $ | (96,145 | ) | |||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||
|
Increase in prepaid expenses
|
1,875 | 1,875 | (625 | ) | ||||||||
|
Increase in accounts payable and accrued expenses
|
1,015 | 2,284 | 11,404 | |||||||||
|
Net cash used in operating activities
|
(2,264 | ) | (147 | ) | (85,366 | ) | ||||||
|
Financing activities
|
||||||||||||
|
Proceeds from notes payable, stockholders
|
- | - | 70,000 | |||||||||
|
Payments on notes payable, stockholders
|
- | - | (10,000 | ) | ||||||||
|
Proceeds from issuance of common stock
|
- | - | 50,000 | |||||||||
|
Net cash provided by financing activities
|
- | - | 110,000 | |||||||||
|
Net increase (decrease) in cash and cash equivalents
|
(2,264 | ) | (147 | ) | 24,634 | |||||||
|
Cash and cash equivalents at beginning of period
|
26,898 | 11,142 | - | |||||||||
|
Cash and cash equivalents at end of period
|
$ | 24,634 | $ | 10,995 | $ | 24,634 | ||||||
|
1.
|
Nature of Operations and Significant Accounting Policies
|
|
1.
|
Nature of Operations and Significant Accounting Policies (continued)
|
|
2.
|
Notes Payable, Stockholders
|
|
3.
|
Preferred Stock
|
|
4.
|
Common Stock
|
|
5.
|
Income Taxes
|
|
6.
|
Commitment
|
|
|
(i)
|
filing Exchange Act reports, and
|
|
|
(ii)
|
investigating, analyzing and consummating an acquisition.
|
|
Three Months
Ended
March 31, 2011
|
Three Months
Ended
March 31, 2010
|
For the
Cumulative
Period from
November 16,
2007 (Inception)
to
March 31, 2011
|
||||||||||
|
Net Cash (Used in) Operating Activities
|
$ | (2,264 | ) | $ | (147 | ) | $ | (85,366 | ) | |||
|
Net Cash (Used in) Investing Activities
|
$ | - | $ | - | $ | - | ||||||
|
Net Cash Provided by Financing Activities
|
$ | - | $ | - | $ | 110,000 | ||||||
|
Net Increase (decrease) in Cash and Cash Equivalents
|
$ | (2,264 | ) | $ | (147 | ) | $ | 24,634 | ||||
|
Exhibit
|
Description
|
|
|
*3.1
|
Certificate of Incorporation, as filed with the Delaware Secretary of State on November 16, 2007.
|
|
|
*3.2
|
By-Laws.
|
|
|
31.1
|
Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011.
|
|
|
31.2
|
Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011.
|
|
|
32.1
|
Certification of the Company’s Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
Certification of the Company’s Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
*
|
Filed as an exhibit to the Company's Registration Statement on Form 10-SB, as filed with the SEC on February 1, 2008, and incorporated herein by this reference.
|
|
Dated: May 16, 2011
|
ZETA ACQUISITION CORP. II
|
|
|
By:
|
/s/ John Pappajohn
|
|
|
John Pappajohn
|
||
|
President and Director
|
||
|
Principal Executive Officer
|
||
|
By:
|
/s/ Matthew P. Kinley
|
|
|
Matthew P. Kinley
|
||
|
Secretary, Chief Financial Officer and Director
|
||
|
Principal Financial Officer
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|